Invasive lobular carcinoma accounts for about 10% of breast cancer diagnoses. Its incidence is increasing at the rate of 2.8% annually -- more than triple that of other breast cancers combined. This ...

MSK created this program because we’re experts in treating this type of cancer. Lobular breast cancer is very different from invasive ductal carcinoma, the most common type of breast cancer. It’s ...

Based on WHO classification, Breast carcinomas have varying histomorphologies and each subtype has its own translational importance. Invasive lobular ...

Invasive lobular carcinoma (ILC) represents the most common special subtype of breast cancer. Studies show challenges with imaging, surgical therapy, and systemic therapy selection, arguing for the ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...

Lobular breast cancer rates increased 2.8 percent per year over the past decade, compared with a 0.8 percent annual increase for all other breast cancers. Lobular breast cancer grows in a linear ...

Changes in the degree of satisfaction and quality of life in breast cancer patients who are candidates for breast conservation but opted for mastectomy: A single-center prospective study. This is an ...

Studying a person’s genetic makeup can predict if they will go on to develop invasive breast cancer after abnormal cells have been found in their breast tissue. For the first time, researchers at King ...

A genetic risk score could one day guide more personalized treatment for high-risk women, while sparing low-risk women from unnecessary procedures. A new genetic analysis could help predict whether ...